Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Population-Based Analysis of Elderly Patients (>70 YEARS) with Peripheral T-CELL Lymphoma: A Results from Czech Lymphoma Study Group (CLSG) Registry

Andrea Janikova, MD PhD, Assoc Prof, Robert Pytlik, MD, Pavel Klener, MD PhD, Zbynek Bortlicek, PhD, Vit Campr, MD PhD, Natasa Kopalova, Mgr, Katerina Benesova, MD PhD, Michaela Hamouzova, David Belada, MDPhD, Vit Prochazka, MD PhD ass. prof., Jan Pirnos, MD, Juraj Duras, MD, Heidi Mocikova, MD, PhD, Jiri Mayer, MD, Marek Trneny

Blood (2016) 128 (22): 3000.

https://doi.org/10.1182/blood.V128.22.3000.3000

Published: 2016

Journal Articles

Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) Is a New Biomarker for Mantle Cell Lymphoma: Expression, Localization, and Phosphorylation Study

Tomas Stopka, MD PhD, Jarmila Vargova, MSc, Karina Vargova, PhD, Nina Dusilkova, MD, Vojtech Kulvait, MSc, Vit Pospisil, PhD, Jiri Zavadil, PhD, Marek Trneny, Pavel Klener, MD PhD

Blood (2016) 128 (22): 1767.

https://doi.org/10.1182/blood.V128.22.1767.1767

Published: 2016

Journal Articles

B-Cell Receptor Driven MALT1 Activity Regulates MYC Signaling in Mantle Cell Lymphoma

Blood (2016) 128 (22): 611.

https://doi.org/10.1182/blood.V128.22.611.611

Published: 2016

Journal Articles

Immunomodulatory Agent Lenalidomide Enhances Antitumor Functions of Chimeric Receptor-Modified T Cells in Vitro and in Vivo

Otáhal Pavel, MD PhD, Dana Prukova, PhD, Vlastimil Král, PhD, Radek Jaksa, MD, Lucie Lateckova, MD, Petra Vockova, MD, Barbora Svobodova, Marek Trneny, MD, PhD, Prof., Pavel Klener, MD, PhD

Blood (2014) 124 (21): 805.

https://doi.org/10.1182/blood.V124.21.805.805

Published: 2014

Journal Articles

Hematopoietic Stem and Progenitor Cells in Patients with Mature B-Cell Malignancies Are Quantitatively and Qualitatively Deregulated Compared to Healthy Controls

Bokang Maswabi, MD, Dana Prukova, PhD, Jan Molinsky, MD PhD, Magdalena Klanova, MD, Lucie Lateckova, MD, Petra Vockova, MD, Tomas Zikmund, MSc, Filipp Savvulidi, MSc, Mahmudul Alam, PhD, Dana Vejmelkova, PhD, Radek Jaksa, MD, Ludek Sefc, PhD, Martin Vokurka, MD PhD, Marek Trneny, Pavel Klener, MD PhD

Blood (2014) 124 (21): 4307.

https://doi.org/10.1182/blood.V124.21.4307.4307

Published: 2014

Journal Articles

The Outcome of Mantle Cell Lymphoma patients after Treatment Failure and Prognostic value of Secondary Mantle Cell International Prognostic Index (sec MIPI)

Marek Trneny, MD, Pavel Klener, MD, David Belada, MD, Heidi Mocikova, MD, PhD, Vit Prochazka, MD, Samuel Vokurka, MD PhD, Jan Pirnos, MD, Katerina Kubackova, MD, Juraj Duras, MD, Jana Salkova, MD, David Salek, MD, Robert Pytlik, MD, PhD, Lucie Barsova, MD, Petr Kessler, MD, Ludmila Boudova, MD, Vit Campr, MD, PhD, Radek Jaksa, MD, Jitka Dlouha, Katerina Benesova, MD

Blood (2014) 124 (21): 4425.

https://doi.org/10.1182/blood.V124.21.4425.4425

Published: 2014

Journal Articles

Observational Study Alternating R-CHOP21 and R-Cytarabine (3+3 Cycles) for Patients with Newly Diagnosed Mantle Cell Lymphoma Not Eligible for High-Dose Therapy: A Czech Lymphoma Study Group Trial Preliminary Results

Pavel Klener, MD, PhD, Eva Fronkova, MD, PhD, Robert Pytlik, MD, PhD, Marketa Kalinova, D.Sc., PhD, Kristina Forsterova, D.Sc., PhD, David Belada, MD, Martin Simkovic, MD, David Salek, MD, PhD, Heidi Mocikova, MD, PhD, Vit Prochazka, MD, PhD, Vit Campr, MD, PhD, Radek Jaksa, MD, Jozef Kubinyi, MD, PhD, Jiri Dolezal, MD, PhD, Ass.Prof., Jan Trka, MD, PhD, Prof., Marek Trneny, MD, PhD, Prof.

Blood (2014) 124 (21): 1720.

https://doi.org/10.1182/blood.V124.21.1720.1720

Published: 2014

Journal Articles

CD200 Expression Improves Differential Diagnosis Between Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma

Martin Spacek, MD, PhD, Josef Karban, MD, Martin Radek, Eva Babunkova, Jan Kvasnicka, Prof., MD PhD, Radek Jaksa, MD, Adela Berkova, MD, Pavel Klener, MD PhD, Marek Trneny

Blood (2014) 124 (21): 5637.

https://doi.org/10.1182/blood.V124.21.5637.5637

Published: 2014

Journal Articles

MCL1 Targeting Agent Homoharringtonine Exerts Strong Cytotoxicity Towards Diffuse Large B-Cell Lymphoma (DLBCL) Cells and Synergizes with BCL2 Targeting Agent ABT199 in Eliminating BCL2-Positive DLBCL Cells

Magdalena Klanova, MD, Ladislav Andera, M.Sc. PhD, Jan Soukup, MDPhD, Brazina Jan, M.Sc., Jan Svadlenka, M.Sc., Simona Benesova, M.Sc., Dana Prukova, M.Sc. PhD, Dana Vejmelkova, M.Sc., Radek Jaksa, MD, Karel Helman, PhD, Petra Vockova, MD, Lucie Lateckova, MD, Jan Molinsky, MD PhD, Bokang Maswabi, MD, Mahmudul Alam, PhD, Roman Kodet, Prof. MD, Marek Trneny, Pavel Klener, MD, PhD

Blood (2014) 124 (21): 3645.

https://doi.org/10.1182/blood.V124.21.3645.3645

Published: 2014

Journal Articles

A Lack of Correlation between EVI1 Expression, MDS Subtype and Karyotype Abnormalities Suggests Multiple Pathways Involved in EVI1 Impact on Hematopoietic Cells in MDS Patients.

Jaroslav Cermak, MD, PhD, Ota Fuchs Ing, PhD, Dana Provaznikova, PhD, Kyra Michalova, PhD, Dana Mikulenkova, MD, Jana Brezinova, RNDr PhD, Pavel Klener, MD, PhD

Blood (2007) 110 (11): 2441.

https://doi.org/10.1182/blood.V110.11.2441.2441

Published: 2007

Journal Articles

Proteomic and mRNA Expression Chip Analysis of Acquired TRAIL-Resistance in Human HL60 Myeloid Leukemia Cells.

Jan Zivny, MD, PhD, Pavel Klener, MD, Ondrej Toman, PhD, Petr Halada, PhD, Robert Ivanek, Tereza Simonova, Ladislav Andera, PhD, Emanuel Necas, MD,DrSc, Jiri Petrak, PhD

Blood (2007) 110 (11): 4155.

https://doi.org/10.1182/blood.V110.11.4155.4155

Published: 2007

Journal Articles

A Limited Impact of Chemotherapy on Prolonged Survival in Myelodysplasia (MDS). An Analysis of 142 Patients with Advanced Disease.

Jaroslav Cermak, MD, PhD, Antonin Vitek, MD, Marcela Lukasova, MD, Petr Cetkovsky, MD,PhD, Pavel Klener, MD,PhD

Blood (2006) 108 (11): 2677.

https://doi.org/10.1182/blood.V108.11.2677.2677

Published: 2006

Journal Articles

Genome-Wide and Functional Analysis of Acquired Resistance to TRAIL/APO2l Mediated Apoptosis of Leukemia Cell Lines.

Jan Zivny, MD,PhD, Pavel Klener, MD, Pavel Prochazka, MD, Sergiu Laehomschi, Ales Vicha, MD,PhD, Tomas Eckschlager, MD,PhD, Ladislav Andera, PhD, Emanuel Necas, MD,PhD

Blood (2006) 108 (11): 4385.

https://doi.org/10.1182/blood.V108.11.4385.4385

Published: 2006

NARROW

Population-Based Analysis of Elderly Patients (>70 YEARS) with Peripheral T-CELL Lymphoma: A Results from Czech Lymphoma Study Group (CLSG) Registry

Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) Is a New Biomarker for Mantle Cell Lymphoma: Expression, Localization, and Phosphorylation Study

B-Cell Receptor Driven MALT1 Activity Regulates MYC Signaling in Mantle Cell Lymphoma

Immunomodulatory Agent Lenalidomide Enhances Antitumor Functions of Chimeric Receptor-Modified T Cells in Vitro and in Vivo

Hematopoietic Stem and Progenitor Cells in Patients with Mature B-Cell Malignancies Are Quantitatively and Qualitatively Deregulated Compared to Healthy Controls

The Outcome of Mantle Cell Lymphoma patients after Treatment Failure and Prognostic value of Secondary Mantle Cell International Prognostic Index (sec MIPI)

Observational Study Alternating R-CHOP21 and R-Cytarabine (3+3 Cycles) for Patients with Newly Diagnosed Mantle Cell Lymphoma Not Eligible for High-Dose Therapy: A Czech Lymphoma Study Group Trial Preliminary Results

CD200 Expression Improves Differential Diagnosis Between Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma

MCL1 Targeting Agent Homoharringtonine Exerts Strong Cytotoxicity Towards Diffuse Large B-Cell Lymphoma (DLBCL) Cells and Synergizes with BCL2 Targeting Agent ABT199 in Eliminating BCL2-Positive DLBCL Cells

A Lack of Correlation between EVI1 Expression, MDS Subtype and Karyotype Abnormalities Suggests Multiple Pathways Involved in EVI1 Impact on Hematopoietic Cells in MDS Patients.

Proteomic and mRNA Expression Chip Analysis of Acquired TRAIL-Resistance in Human HL60 Myeloid Leukemia Cells.

A Limited Impact of Chemotherapy on Prolonged Survival in Myelodysplasia (MDS). An Analysis of 142 Patients with Advanced Disease.

Genome-Wide and Functional Analysis of Acquired Resistance to TRAIL/APO2l Mediated Apoptosis of Leukemia Cell Lines.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only